These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Study of novel pure culture HBCD-1, effectively degrading Hexabromocyclododecane, isolated from an anaerobic reactor.
    Author: Peng X, Huang X, Jing F, Zhang Z, Wei D, Jia X.
    Journal: Bioresour Technol; 2015 Jun; 185():218-24. PubMed ID: 25770469.
    Abstract:
    In this study, two pure strains, named HBCD-1 and HBCD-2, were isolated from a continuous anaerobic reactor over 300-days acclimation, which processed high capability of biodegrading Hexabromocyclododecane. Both of the two strains degraded HBCD diastereomers in different extents, especially strain HBCD-1, which interestingly degraded α-HBCD effectively. All of the degrading results were well fitted with the first-order kinetics model. By morphological observation and 16S rRNA gene sequence analysis, the strain HBCD-1 showed highest similarity with Achromobacter sp. Under the optimal culturing conditions of 30°C, pH 7 and the initial HBCD concentration of 500μg/L, the biodegradation rate of HBCD-1 reached 90% after 8days treatment. Moreover, during the biodegradation process by HBCD-1 strain, the concentration of bromide ion was lower than the theoretical value. Finally, 4 metabolites were determined by liquid chromatography-tandem mass spectrometry (LC-MS/MS), as well as a biodegradation pathway was proposed.
    [Abstract] [Full Text] [Related] [New Search]